Soluble IL-2 Α and Ovarian Cancer

British Journal of Cancer- United Kingdom

doi 10.1038/bjc.1994.117

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

IL-6 and Ovarian Cancer--Response

Clinical Cancer Research
Cancer ResearchOncology
2011English

IL-2; IL-2 Receptor Α-Chain (IL2-RA; CD25); IL-2 Receptor Β-Chain (IL2-RB; CD122)

Science-Business eXchange
2012Maltese

Inhibition of MK2 Suppresses IL-1β, IL-6, and TNF-α Dependent Colorectal Cancer Growth

International Journal of Cancer
Cancer ResearchOncology
2017English

Serum Folate Receptor Α (sFR) in Ovarian Cancer Diagnosis and Surveillance

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Mda-7/Il-24 Differentially Regulates Soluble and Nuclear Clusterin in Prostate Cancer

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2013English

TGF-β1 and IL-10 Expression in Epithelial Ovarian Cancer Cell Line A2780

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2016English

Prospects of IL-2 in Cancer Immunotherapy

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Soluble VEGF Receptor 1 (sFLT1) Induces Non-Apoptotic Death in Ovarian and Colorectal Cancer Cells

Scientific Reports
Multidisciplinary
2016English

Generation and Regulation of Human CD4+ IL-17-producing T Cells in Ovarian Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy